Cargando…
Liraglutide attenuates the osteoblastic differentiation of MC3T3-E1 cells by modulating AMPK/mTOR signaling
Liraglutide, a synthetic analogue of glucagon-like peptide-1, is utilized in the treatment of type 2 diabetes and obesity. Liraglutide has been previously demonstrated to prevent osteoblastic differentiation of human vascular smooth muscle cells, resulting in the slowing of arterial calcification, h...
Autores principales: | Hu, Xiong-Ke, Yin, Xin-Hua, Zhang, Hong-Qi, Guo, Chao-Feng, Tang, Ming-Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042760/ https://www.ncbi.nlm.nih.gov/pubmed/27600753 http://dx.doi.org/10.3892/mmr.2016.5729 |
Ejemplares similares
-
Liraglutide Promotes Osteoblastic Differentiation in MC3T3-E1 Cells by ERK5 Pathway
por: Sun, Yue, et al.
Publicado: (2020) -
Strontium promotes osteogenic differentiation by activating autophagy via the the AMPK/mTOR signaling pathway in MC3T3-E1 cells
por: Cheng, You, et al.
Publicado: (2019) -
Liraglutide Improves Endothelial Function via the mTOR Signaling Pathway
por: Wu, Han, et al.
Publicado: (2021) -
Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR
por: Feng, Xiaofeng, et al.
Publicado: (2020) -
AMPK–mTOR Signaling and Cellular Adaptations in Hypoxia
por: Chun, Yoomi, et al.
Publicado: (2021)